HIV associated nephropathy cost-effectiveness of therapy: Difference between revisions
Created page with "__NOTOC__ {{HIV associated nephropathy}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References..." |
No edit summary |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{HIV associated nephropathy}} | {{HIV associated nephropathy}} | ||
{{CMG}} {{AE}} {{SHA}} | |||
==Overview== | |||
The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.<ref name="urlWHO | HIV/AIDS" /> There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | |||
==Cost-effectiveness of Therapy== | |||
*There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | |||
*The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS is as the following for 2018:<ref name="urlWHO | HIV/AIDS">{{cite web |url=https://www.who.int/gho/hiv/en/ |title=WHO | HIV/AIDS |format= |work= |accessdate=}}</ref> | |||
**People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018 | |||
**Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018 | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 7: | Line 19: | ||
{{WS}} | {{WS}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:HIV/AIDS]] | [[Category:HIV/AIDS]] | ||
[[Category:Immune system disorders]] | [[Category:Immune system disorders]] | ||
[[category:viral diseases]] | [[category:viral diseases]] | ||
Latest revision as of 07:47, 5 July 2020
|
HIV associated nephropathy Microchapters |
|
Differentiating HIV associated nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV associated nephropathy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of HIV associated nephropathy cost-effectiveness of therapy |
|
FDA on HIV associated nephropathy cost-effectiveness of therapy |
|
CDC on HIV associated nephropathy cost-effectiveness of therapy |
|
HIV associated nephropathy cost-effectiveness of therapy in the news |
|
Blogs on HIV associated nephropathy cost-effectiveness of therapy |
|
Risk calculators and risk factors for HIV associated nephropathy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
The World Health Organization (WHO) data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.[1] There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
Cost-effectiveness of Therapy
- There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
- The World Health Organization (WHO) data on HIV/AIDS is as the following for 2018:[1]
- People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018
- Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018